Disruption of adiponectin causes insulin resistance and neointimal formation
about
Drug-induced diabetes mellitusC1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose outputAdiponectin promotes migration activities of endothelial progenitor cells via Cdc42/Rac1Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersT-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectinInflammatory peptides derived from adipose tissueHypothalamic AMPK as a Regulator of Energy HomeostasisAdiponectin signaling and function in insulin target tissuesPerspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in ObesityCross-Talk between Adiponectin and IGF-IR in Breast CancerAdiponectin as a potential biomarker of vascular diseaseAdiponectin, driver or passenger on the road to insulin sensitivity?Inflammation and metabolic dysfunction: links to cardiovascular diseasesEffect of bariatric surgery on humoral control of metabolic derangements in obese patients with type 2 diabetes mellitus: How it worksMendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetesRole of lipotoxicity in endothelial dysfunctionAdipocytokines and obesity-linked disordersCrystal structure of a single-chain trimer of human adiponectin globular domainLipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review)Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic StrategiesLow plasma adiponectin levels and risk of colorectal cancer in men: a prospective studyHzf regulates adipogenesis through translational control of C/EBPalphaMolecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functionsA family of Acrp30/adiponectin structural and functional paralogsAdiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosisDivergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeAdipocytes as regulators of energy balance and glucose homeostasisInsulin resistance in chronic kidney disease: a systematic review.Adiponectin and its receptors modulate granulosa cell and cumulus cell functions, fertility, and early embryo development in the mouse and human.Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes.T-cadherin (Cdh13) in association with pancreatic β-cell granules contributes to second phase insulin secretionMild gestational diabetes in pregnancy and the adipoinsular axis in babies born to mothers in the ACHOIS randomised controlled trial.Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaquesEfficacy of pioglitazone on glycemic control and carotid intima-media thickness in type 2 diabetes patients with inadequate insulin therapyUltrastructural localization of adiponectin protein in vasculature of normal and atherosclerotic mice.Association between risk factors for vascular dementia and adiponectin.Disulfide-dependent self-assembly of adiponectin octadecamers from trimers and presence of stable octadecameric adiponectin lacking disulfide bonds in vitro.Adiponectin-mediated modulation of hypertrophic signals in the heartCentral adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice
P2860
Q22306015-FEE6A351-2219-4ACF-9B8A-878E36E3FAD4Q24303598-D878AF5F-D544-482E-A292-57E3D5CBDED3Q24314229-800BB115-79F4-4CAB-8AF0-4900EFFA8730Q24562763-56DDA7E8-1C6B-455C-B135-FBC9C83E635AQ24564272-8FB41C46-862D-433B-97B0-39A94A781081Q24800707-27261461-054D-48E3-9BE5-AB4DD9782F87Q26740075-186DAC2B-0DF9-4353-BEC0-1630B400F764Q26753354-5407D107-0980-47FF-87C9-FDCEF11CE868Q26777180-A6E84F1E-FDA7-4C57-AE21-E35FD2F230B4Q26799865-552C4C28-FFAE-4948-B16C-1CBBA0562477Q26821925-284B006B-BB9A-4AF7-94CD-B6B31D37D5DBQ26827971-27B30599-5963-478F-83D7-E1A5E86BDC36Q26851186-61AEF5D7-7300-49DA-B27C-C446DBCF4443Q26852039-E7FB52CA-D985-457B-B709-744FCF14E3AAQ26861535-74EBD81A-9C47-48DE-BB16-DD8E54ABE594Q27000731-E65EEAA6-2BEF-4473-B971-1B70C5F22D75Q27021977-8FE3BF07-3B93-4EEA-AF43-A05FC01B037DQ27678213-056DAE7B-0A18-47C1-8536-1E33AEE556BFQ28083206-8F6B7AE7-A957-4B7D-BCA7-96969E0ECAC8Q28088325-000BBEC8-B9DE-4B63-AF08-4B08F067FD82Q28193386-CFAAD454-F0A4-488B-AFFF-DEAD223B97EBQ28507261-099D8CD4-B76C-48FB-B463-A5BC4BA602F5Q28508387-FEA58515-FF33-4857-B155-E3B475008CB2Q28513966-427DA686-3298-4180-BDB4-AD51FE4E816DQ28584013-5E6C3D43-6C37-4105-9338-D79A49B82574Q28591569-4C971151-60AA-4643-88B0-4C8BDE08725DQ29619211-66C2D7D5-2A58-44F0-810B-F0DAA1EAB0D0Q29619448-BD500EBB-5BBD-45C0-9C78-C4FEA1509448Q30244271-E7902841-75EA-4E39-B2E4-B5AD62262AA9Q30417883-C4587379-8E82-4BC0-ADA1-B739B0E25D18Q30440168-F86DC852-160B-40DF-B523-0E960639BD43Q30513489-2C83CDD7-3D2F-47F6-ACDE-F8AEBE7B849DQ33281967-B5B89FC5-D2B0-4928-82C2-AB21DD4BD1B3Q33415488-78298E8C-50FA-4756-B6B8-05A7B1478B59Q33558402-B5B4BAF7-BFF0-4A27-96A1-3ECE732AFD75Q33581743-299D3BAB-58AA-40D9-BFB0-A2E1832092C9Q33594133-43D38F36-170A-46C7-9535-23595F040AB6Q33596343-FEDF224B-5000-48E9-8D6C-C73F30ADACC4Q33688678-D324E060-AC34-48A6-93D1-E56883339955Q33764646-9E5CFD0B-3E6A-4160-AAD3-4C890D302084
P2860
Disruption of adiponectin causes insulin resistance and neointimal formation
description
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2002
@ast
im Juli 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/07/19)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/07/19)
@nl
наукова стаття, опублікована в липні 2002
@uk
name
Disruption of adiponectin causes insulin resistance and neointimal formation
@ast
Disruption of adiponectin causes insulin resistance and neointimal formation
@en
Disruption of adiponectin causes insulin resistance and neointimal formation
@nl
type
label
Disruption of adiponectin causes insulin resistance and neointimal formation
@ast
Disruption of adiponectin causes insulin resistance and neointimal formation
@en
Disruption of adiponectin causes insulin resistance and neointimal formation
@nl
prefLabel
Disruption of adiponectin causes insulin resistance and neointimal formation
@ast
Disruption of adiponectin causes insulin resistance and neointimal formation
@en
Disruption of adiponectin causes insulin resistance and neointimal formation
@nl
P2093
P3181
P356
P1476
Disruption of adiponectin causes insulin resistance and neointimal formation
@en
P2093
Hidemi Satoh
Junji Kamon
Junji Matsui
Kazuhiro Eto
Masao Moroi
Naoto Kubota
Ryozo Nagai
Satoshi Kimura
Takashi Kadowaki
Tetsuo Noda
P304
25863–25866
P3181
P356
10.1074/JBC.C200251200
P407
P577
2002-07-19T00:00:00Z